Effect of the combined treatment with myo-inositol and metformin on the phenotype of the polycystic ovary syndrome: a pilot study - UOE/08/03

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2009年6月19日最近更新: 2014年2月24日

适应症

试验速览

暂无简介。

•Inclusion criteria are: i) diagnosis of PCOS according to the National Institutes of Health (NIH) 1999 criteria; ii) body Mass Index (BMI) (Kg/m2) values greater than 19 and lower than or equal to 27 kg/m2; iii) age between 18 and 44 years
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Exclusion criteria are: i) diabetes in insulin failure; ii) renal, hepatic, or cardiac chronic diseases; iii) low compliance; iv) chronic uses of drugs; v) menopause; vi) Pregnancy or breast-feeding, or women planning to become pregnant (excluded by pregnancy test); vii) Unability to follow the procedures set by the Protocol and to sign the informed consent.

发起方

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI